Cargando…
Mesenchymal stem cell-derived exosomal miR-146a reverses diabetic β-cell dedifferentiation
BACKGROUND: Mesenchymal stem cells (MSCs) show promising therapeutic potential in treating type 2 diabetes mellitus (T2DM) in clinical studies. Accumulating evidence has suggested that the therapeutic effects of MSCs are not due to their direct differentiation into functional β-cells but are instead...
Autores principales: | He, Qin, Song, Jia, Cui, Chen, Wang, Jinbang, Hu, Huiqing, Guo, Xinghong, Yang, Mengmeng, Wang, Lingshu, Yan, Fei, Liang, Kai, Liu, Zhaojian, Liu, Fuqiang, Sun, Zheng, Dong, Ming, Hou, Xinguo, Chen, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356465/ https://www.ncbi.nlm.nih.gov/pubmed/34380570 http://dx.doi.org/10.1186/s13287-021-02371-0 |
Ejemplares similares
-
Retraction Note: Mesenchymal stem cell-derived exosomal miR-146a reverses diabetic β-cell dedifferentiation
por: He, Qin, et al.
Publicado: (2022) -
Mesenchymal stromal cells ameliorate diabetes‐induced muscle atrophy through exosomes by enhancing AMPK/ULK1‐mediated autophagy
por: Song, Jia, et al.
Publicado: (2023) -
Mesenchymal stem cell-derived exosomes exert ameliorative effects in type 2 diabetes by improving hepatic glucose and lipid metabolism via enhancing autophagy
por: He, Qin, et al.
Publicado: (2020) -
Retraction Note: Mesenchymal stem cell-derived exosomes exert ameliorative effects in type 2 diabetes by improving hepatic glucose and lipid metabolism via enhancing autophagy
por: He, Qin, et al.
Publicado: (2022) -
Multiple Myeloma-Derived Exosomes Regulate the Functions of Mesenchymal Stem Cells Partially via Modulating miR-21 and miR-146a
por: Cheng, Qian, et al.
Publicado: (2017)